Deepak Sarwal, MD
Endocrinology, Diabetes & Metabolism · Dayton, OHNPI 1235159559
Payments from drug & device makers
Across 643 payments — averaging $112.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$47K
- GSK$12K
- AbbVie$2K
- Novo Nordisk$2K
- Medtronic$1K
- Bayer$1K
- plus $7K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 5 | $47,141 |
| GSK | 3 | $12,150 |
| AbbVie(2 entities) | 123 | $2,222 |
| Novo Nordisk | 84 | $1,526 |
| Medtronic(2 entities) | 30 | $1,208 |
| Bayer | 55 | $1,162 |
| Lilly USA, LLC | 51 | $963 |
| Xeris Pharmaceuticals, Inc. | 34 | $718 |
| Boehringer Ingelheim | 21 | $632 |
| Johnson & Johnson | 19 | $449 |
| Dexcom, Inc. | 13 | $403 |
| Otsuka America Pharmaceutical, Inc. | 10 | $361 |
| Pfizer | 30 | $360 |
| Insulet Corporation | 20 | $346 |
| Corcept Therapeutics | 24 | $313 |
| Tandem Diabetes Care, Inc. | 9 | $277 |
| BETA Bionics, Inc. | 10 | $277 |
| Abbott | 9 | $268 |
| Astellas Pharma US Inc | 11 | $255 |
| AstraZeneca | 14 | $218 |
| Cequr Corporation | 3 | $213 |
| Evoke Pharma, Inc. | 5 | $163 |
| Amarin Pharma, Inc. | 20 | $153 |
| Sanofi-aventis U.S. LLC | 5 | $142 |
| Merck | 7 | $118 |
| Amphastar Pharmaceuticals, Inc. | 5 | $84 |
| Madrigal Pharmaceuticals | 3 | $75 |
| Novartis | 3 | $61 |
| Biohaven Pharmaceuticals, Inc. | 1 | $47 |
| Mannkind Corporation | 1 | $45 |
| Sequel Med Tech, LLC | 2 | $43 |
| Exact Sciences | 2 | $37 |
| Renalytix AI, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Zealand Pharma US, Inc. | 1 | $31 |
| Lundbeck LLC | 2 | $28 |
| Eisai Inc. | 1 | $27 |
| Bigfoot Biomedical Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Amgen | 1 | $12 |
How this compares
$72,626 in reported general payments places this provider in the 85th percentile of 312 endocrinology, diabetes & metabolism providers in Ohio.
See all endocrinology, diabetes & metabolism providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Dayton
- Trisha ZeidanDayton$124K
- Ankur GuptaDayton$28K
- Toby BriskinBedford$9.8M
- Charles SmithCanton$5.3M
- Kevin PantaloneCleveland$4M
- Elena ChristofidesColumbus$3.5M
- Arvind KrishnaCanton$3.1M
- Bartolome BurgueraCleveland$3.1M
- Steven IngColumbus$1.9M
- Kathleen DunganColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.